Literature DB >> 18618902

Sedation and antihistamines: an update. Review of inter-drug differences using proportional impairment ratios.

Kathleen McDonald1, Leanne Trick, Julia Boyle.   

Abstract

BACKGROUND: The use of antihistamines (AHs) has been associated with cognitive and psychomotor impairments, largely caused by the sedative properties of many of these drugs. Due to the ambulant nature of the population using AHs, it is important to evaluate these effects using standardised methodology and psychometric tests. A previous extensive review of the literature collated the results of studies of H(1) receptor antagonists to determine the extent to which a particular AH produced impairments on a battery of psychometric tests by calculating a proportional impairment ratio for each AH.
OBJECTIVE: In light of a number of major studies published following the previous review, and the development of the second and new-generation AHs, the present review aims to add to the database and update the review, using the same methodology. RESULTS AND
CONCLUSION: The newer generation AHs appear to be the least impairing, and the first generation, as expected, appear to be the most impairing. There are also differences within the AH drug generations. The review highlights the necessity to consider the sedating potential of AHs, along with other factors such as efficacy, when prescribing AHs to ambulant patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18618902     DOI: 10.1002/hup.962

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  11 in total

1.  Preclinical assessment of CNS drug action using eye movements in mice.

Authors:  Hugh Cahill; Amir Rattner; Jeremy Nathans
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

2.  Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study.

Authors:  Consuelo García-Gea; Maria Rosa Ballester; Juan Martínez; Rosa Maria Antonijoan; Esther Donado; Iñaki Izquierdo; Manuel-José Barbanoj
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

3.  Otitis media and antihistamines.

Authors:  Timothy Goodrich; Frank Rubio; Jeffrey L Cutler
Journal:  Curr Allergy Asthma Rep       Date:  2009-11       Impact factor: 4.806

4.  Serum Histidine is Lower in Fatigued Women with Multiple Sclerosis.

Authors:  Bryan D Loy; Brett W Fling; Kylie M Sage; Rebecca I Spain; Fay B Horak
Journal:  Fatigue       Date:  2019-05-07

Review 5.  Cutaneous Drug Reactions in the Elderly.

Authors:  James W S Young; Neil H Shear
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 4.271

6.  Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines.

Authors:  S Rico; Rm Antonijoan; Mj Barbanoj
Journal:  J Asthma Allergy       Date:  2009-08-31

Review 7.  Central nervous system effects of the second-generation antihistamines marketed in Japan--review of inter-drug differences using the proportional impairment ratio (PIR)-.

Authors:  Tatsuya Isomura; Takeshi Kono; Ian Hindmarch; Norimasa Kikuchi; Aya Murakami; Kyoko Inuzuka; Seiji Kawana
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

8.  On-the-road driving performance after use of the antihistamines mequitazine and l-mequitazine, alone and with alcohol.

Authors:  N N J J M van der Sluiszen; A Vermeeren; S Jongen; E L Theunissen; A C M van Oers; C J Van Leeuwen; A Maret; C Desforges; A Delarue; J G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2016-08-04       Impact factor: 4.530

9.  Brain histamine H1 receptor occupancy after oral administration of desloratadine and loratadine.

Authors:  Tadaho Nakamura; Kotaro Hiraoka; Ryuichi Harada; Takuro Matsuzawa; Yoichi Ishikawa; Yoshihito Funaki; Takeo Yoshikawa; Manabu Tashiro; Kazuhiko Yanai; Nobuyuki Okamura
Journal:  Pharmacol Res Perspect       Date:  2019-07-12

10.  The anti-inflammatory effects of levocetirizine--are they clinically relevant or just an interesting additional effect?

Authors:  Garry M Walsh
Journal:  Allergy Asthma Clin Immunol       Date:  2009-12-17       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.